AVEO Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
AVEO Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AVEO Pharmaceuticals Inc
Access all reports
AVEO Pharmaceuticals Inc. was a biopharmaceutical company focused on the development and commercialization of oncology therapeutics. The company engaged in clinical research and regulatory advancement of targeted cancer treatments. It served healthcare providers and patients in the oncology sector. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
AVEO
Country
🇺🇸 United States